ArticleNeurology and therapy2024

Safety and Effectiveness of Satralizumab in Japanese Patients with Neuromyelitis Optica Spectrum Disorder: A 6-month Interim Analysis of Post-marketing Surveillance.

Takashi Yamamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.